Zhejiang Medicine Co., Ltd. (ZMC), a global manufacturer and supplier of drug products, APIs and intermediates, human and animal nutritional products, has the following manufacturing sites:

• ZMC Xinchang Pharmaceutical Factory
• ZMC Changhai Biological Company
• ZMC Vitamin Factory
• Zhejiang Novus Pharmaceuticals Co., Ltd.
• Zhejiang Changhai Pharmaceuticals Co., Ltd., and
• Zhejiang Health Creation Biotechnology Co., Ltd.

ZMC employs over 6800 people and maintains assets of USD 1.5 billion, while generating revenue of USD 1 billion in 2018.

ZMC operates occupational hygiene, safety and environmental protection management systems that are compliant with ISO 14001 and OHSAS18001 standards. The APIs facilities are cGMP compliant with successful inspections from the German HA, Australian TGA, PMDA,WHO and US FDA. In addition to the aforementioned compliant status, ZMC human nutrition products have been certified or verified by USP DIVP, HACCP and ISO22001; natural origin products have been IP certified and animal nutritional products have been FAMI-QS certified.

The FDFs manufacturing facilities are designed and built to not only meet NMPA requirements but also international regulatory requirements. The products are competitive both on quality and cost. 

ZMC is committed to its corporate mission of “Caring for the Health of Mankind” by offering the highest quality products to promote human health.